Skip to main content
Erschienen in: Diabetologia 6/2019

08.04.2019 | Review

Digital health technology and mobile devices for the management of diabetes mellitus: state of the art

verfasst von: Rongzi Shan, Sudipa Sarkar, Seth S. Martin

Erschienen in: Diabetologia | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Diabetes mellitus is a disease that can be difficult to manage and requires high levels of health literacy and numeracy, self-monitoring and frequent contact with clinicians. If not optimally controlled, diabetes can lead to kidney failure, blindness and cardiovascular complications, which, in turn, contribute to increasing healthcare costs. Although not yet widely used, mobile health (mHealth) tools have enhanced diabetes management and prevention and are likely to play an increasing role with the growth of smartphone ownership and medical device innovations. Recent mHealth interventions targeting type 1 and type 2 diabetes are diverse in their goals and components, and include insulin management applications, wearable blood glucose meters, automated text messages, health diaries and virtual health coaching. In this paper, we review the modalities and components of various impactful interventions for insulin management, diabetes education, self-management and prevention. More work is needed to investigate how individual demographic, socioeconomic, behavioural and clinical characteristics contribute to patient engagement and the efficacy of mHealth tools for diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Charpentier G, Benhamou P-Y, Dardari D et al (2011) The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 34(3):533–539. https://doi.org/10.2337/dc10-1259 CrossRefPubMedPubMedCentral Charpentier G, Benhamou P-Y, Dardari D et al (2011) The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 34(3):533–539. https://​doi.​org/​10.​2337/​dc10-1259 CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Rossi MCE, Nicolucci A, Di Bartolo P et al (2010) Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care 33(1):109–115. https://doi.org/10.2337/dc09-1327 CrossRefPubMed Rossi MCE, Nicolucci A, Di Bartolo P et al (2010) Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care 33(1):109–115. https://​doi.​org/​10.​2337/​dc09-1327 CrossRefPubMed
29.
Zurück zum Zitat Ohannessian R, Yaghobian S (2017) Financing telemedicine in France: a descriptive retrospective study. J Int Soc Telemed eHealth 5(GKR):e35 Ohannessian R, Yaghobian S (2017) Financing telemedicine in France: a descriptive retrospective study. J Int Soc Telemed eHealth 5(GKR):e35
38.
Zurück zum Zitat Vervloet M, van Dijk L, de Bakker DH et al (2014) Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with type 2 diabetes: evidence from a randomized controlled trial. Diabet Med 31(7):821–828. https://doi.org/10.1111/dme.12439 CrossRefPubMed Vervloet M, van Dijk L, de Bakker DH et al (2014) Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with type 2 diabetes: evidence from a randomized controlled trial. Diabet Med 31(7):821–828. https://​doi.​org/​10.​1111/​dme.​12439 CrossRefPubMed
Metadaten
Titel
Digital health technology and mobile devices for the management of diabetes mellitus: state of the art
verfasst von
Rongzi Shan
Sudipa Sarkar
Seth S. Martin
Publikationsdatum
08.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 6/2019
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-4864-7

Weitere Artikel der Ausgabe 6/2019

Diabetologia 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.